A retrospective study of 96 patients with metastatic colorectal cancer found KRAS mutations in 63.54% of patients, predominantly in codon 12 (70.49%) and codon 13 (14.75%). (Arq Bras Cir Dig)
KRAS mutations in 63.54% of metastatic CRC patients
The CRC Digest